Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sequenom Inc (SQNM)

Sequenom Inc (SQNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sequenom Inc 3595 JOHN HOPKINS COURT SAN DIEGO CA 92121

www.sequenom.com P: 858-202-9000

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds.

Key Statistics

Overview:

Market Capitalization, $K 286,180
Shares Outstanding, K 119,220
% of Insider Shareholders 3.10%
% of Institutional Shareholders 46.03%

Financials:

Annual Sales, $ 128,280 K
Annual Net Income, $ -16,330 K
Last Quarter Sales, $ 29,290 K
Last Quarter Net Income, $ -6,310 K

Growth:

1-Year Return 21.32%
3-Year Return -16.72%
5-Year Return -60.17%
5-Year Revenue Growth 170.29%
5-Year Earnings Growth -84.62%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 05/04/16
Next Earnings Date 11/02/16
Earnings Per Share ttm -0.33
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 37.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 04/30/09

SQNM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -35.58%
Profit Margin % -12.73%
Debt/Equity -3.50
Price/Sales 2.23
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.46
Interest Coverage 0.00
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar